DuPont de Nemours, Inc. DD

IndustrialsChemicalsUnited States of America

Last close 140.05 USD on Nov 1, 2026, +17.6% year to date

Quant rating

Quant rating C Rank 265 of 486 in Industrials

Growth D 401 of 486
Valuation C 271 of 486
Quality D 358 of 486
Revisions B 141 of 486
Momentum B 110 of 486

Wall Street consensus Buy (1.95)Average target 164.35 USD +17.4%

Historical valuation

Multiples use consensus estimates for the next twelve months. The dashed line is the 5-year average.

Key data

Market cap: 18.9B
Enterprise value: 20.4B
52-week range: 100.44 – 157.92
3-year range: 69.17 – 157.92
Dividend yield: 1.71%
Beta (5 years): 1.05
Shares outstanding: 135M
Next earnings: Nov 3, 2026

About the company

DuPont de Nemours, Inc. is engaged in providing advanced solutions that help transform industries. The Company serves various markets, including healthcare, water, construction, and industrial. It operates through two segments, which include Healthcare & Water Technologies and Diversified Industrials. The Healthcare & Water Technologies segment includes packaging, parts and components for medical device and biopharma markets as well as water filtration and purification technologies primarily for industrial wastewater & energy, municipal drinking water & desalination, and life sciences & specialty markets. The Diversified Industrials segment includes building technologies, with a portfolio serving new-build and repair/remodel applications across non-residential and residential construction markets, and industrial technologies, which includes a portfolio of adhesive, wear and friction, and packaging solutions serving aerospace, automotive and printing and packaging markets.

Growth and profitability fiscal year ends December 31

Growth and profitability by fiscal year
	2025	2024	2023	2022	2021	5Y avg
Revenue (mil)	6,849	6,719	6,614	13,017	12,566	–
Revenue growth	1.9%	1.6%	−49.2%	3.6%	12.9%	−9.3%
EPS (basic, normalized)	5.04	12.21	10.44	10.23	12.90	–
EPS growth	−58.7%	17.0%	2.1%	−20.7%	–	–
Gross margin	34.5%	33.4%	32.8%	35.5%	36.6%	34.6%
Net margin	0.8%	−1.9%	−1.5%	7.8%	9.2%	2.9%
ROE	0.3%	−0.6%	−0.4%	3.8%	3.6%	1.3%

Balance sheet, last quarter
Cash & short-term investments (mil)	1,740
Current ratio	2.43x
Long-term debt (mil)	3,125
Net debt (mil)	1,497
Total equity (mil)	13,769
Net debt / equity	0.11x
Net debt / EBITDA	0.92x

Estimates and valuation

Consensus estimates and implied multiples
	Sales (mil)			EBITDA (mil)			EPS
Fiscal year	Mean est.	Growth	EV/Sales	Mean est.	Growth	EV/EBITDA	Mean est.	Growth	P/E
2025 actual	6,849	+1.9%	3.0x	1,628	−48.0%	12.5x	5.04	−58.7%	27.8x
2026	7,169	+4.7%	2.8x	1,762	+8.2%	11.6x	7.25	+43.9%	19.3x
2027	7,455	+4.0%	2.7x	1,875	+6.5%	10.9x	7.96	+9.8%	17.6x
2028	7,762	+4.1%	2.6x	1,992	+6.2%	10.2x	8.67	+8.9%	16.2x

Estimate revisions

Change in consensus estimates over 1, 3 and 6 months
	Sales				EPS
Fiscal year	Estimate (mil)	1M	3M	6M	Estimate	1M	3M	6M
2026	7,169	0.0%	+0.1%	+1.0%	7.25	−0.1%	+1.6%	+6.7%
2027	7,455	0.0%	+0.1%	+0.9%	7.96	+0.6%	+1.4%	+4.0%
2028	7,762	−0.1%	+0.3%	+1.5%	8.67	0.0%	+1.2%	+3.5%

Earnings surprises EPS beat in 4 of the last 4 quarters

Reported results versus consensus, last 10 fiscal quarters
Quarter ended	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales reported (mil)	2,931	3,171	3,192	3,092	3,066	3,257	3,072	1,693	1,681	1,819
Sales mean (mil)	2,813	3,049	3,204	3,068	3,042	3,241	2,901	1,688	1,666	1,813
Surprise	+4.2%	+4.0%	−0.4%	+0.8%	+0.8%	+0.5%	+5.9%	+0.3%	+0.9%	+0.3%
EPS reported	2.37	2.91	3.54	3.39	3.09	3.36	3.27	1.38	1.65	1.88
EPS mean	1.94	2.56	3.09	2.94	2.86	3.19	3.18	1.29	1.45	1.76
Surprise	+22.2%	+13.9%	+14.7%	+15.3%	+8.1%	+5.4%	+2.8%	+6.6%	+13.7%	+6.8%

Peer comparison Chemicals

Peers in the same industry group, by market capitalization
Company	Market cap	Net debt/EBITDA	Net margin	P/B	FY1 P/E	FY2 P/E	FY1 EV/EBITDA	FY2 EV/EBITDA
DD DuPont de Nemours, Inc.	18.9B	0.92x	0.8%	1.37x	19.3x	17.6x	11.6x	10.9x
4063 Shin-Etsu Chemical Co., Ltd.	75.1B	−1.36x	18.4%	2.40x	19.6x	17.2x	10.7x	9.5x
1303 Nan Ya Plastics Corp	72.0B	3.88x	1.7%	4.91x	19.9x	13.0x	28.1x	16.5x
LIN Linde PLC	236.1B	1.82x	20.3%	5.99x	28.7x	26.3x	18.3x	17.2x
SHW Sherwin-Williams Co	80.4B	2.50x	10.9%	20.21x	27.6x	25.1x	18.9x	17.8x
ECL Ecolab Inc.	85.0B	3.22x	12.9%	8.15x	37.1x	32.3x	22.2x	19.8x
Mean		1.83x	10.9%	7.17x	25.4x	21.9x	18.3x	15.3x
Median		2.16x	11.9%	5.45x	23.7x	21.3x	18.6x	16.8x

Technical analysis

1M+6.9%
3M−0.1%
1Y+38.7%
3Y+64.0%

Financial statements in millions of USD

Income statement in millions of USD, fiscal years

Income statement, DuPont de Nemours, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Total revenue	6,849	6,719	6,614	13,017	12,566	11,128
Cost of revenue	4,486	4,474	4,442	8,402	7,971	7,063
Gross profit	2,363	2,245	2,172	4,615	4,595	4,065
Selling, general & administrative expenses	1,019	976	891	1,467	1,602	1,492
Research & development	193	203	192	536	557	565
Depreciation/amortization	291	294	267	590	566	542
Interest expense (income), operating	–	–	–	–	–	–
Unusual expense (income)	465	242	773	294	3.0	2,221
Other operating expenses	−25.0	−17.0	−2.0	−7.0	0	−24.0
Operating income	420	547	51.0	1,735	1,867	−731
Net interest income (expense)	−225	−439	−317	−352	−481	−540
Gain (loss) on sale of assets	–	–	–	37.0	28.0	–
Other non-operating income (expense)	5.0	9.0	−13.0	28.0	30.0	12.0
Net income before taxes	200	117	−279	1,448	1,444	−1,259
Provision for taxes	102	213	−217	387	237	90.0
Minority interest	−41.0	−35.0	−39.0	−49.0	−48.0	−28.0
Equity in affiliates	–	–	–	–	–	–
U.S. GAAP adjustment	–	–	–	–	–	–
Net income before extraordinary items	57.0	−131	−101	1,012	1,159	−1,377
Extraordinary items	−836	834	524	4,856	5,308	−1,574
Net income	−779	703	423	5,868	6,467	−2,951
EBIT, normalized	907	791	824	2,029	1,870	1,490
EBITDA, normalized	1,554	1,426	1,404	3,164	2,982	2,576
Basic EPS, normalized	5.04	12.21	10.44	10.23	12.90	–

Balance sheet in millions of USD, fiscal years

Balance sheet, DuPont de Nemours, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Assets
Cash & short-term investments	715	1,792	2,392	4,964	1,972	2,544
Receivables	1,669	1,342	2,370	2,518	2,159	2,421
Total inventory	1,172	1,130	2,147	2,329	2,086	2,393
Prepaid expenses	121	125	194	161	165	164
Other current assets	1,898	16,386	411	1,298	7,921	21,486
Total current assets	5,575	20,775	7,514	11,270	14,303	29,008
Property, plant & equipment	3,867	3,857	6,368	6,157	6,175	7,290
Goodwill	7,915	7,561	16,720	16,663	16,981	18,702
Intangibles	2,936	3,178	5,814	5,495	6,222	8,072
Long-term investments	432	418	1,071	733	919	1,047
Note receivable	–	–	–	–	–	–
Other long-term assets	850	847	1,065	1,037	1,107	6,785
Total assets	21,575	36,636	38,552	41,355	45,707	70,904
Liabilities
Accounts payable	995	1,054	1,675	2,103	2,102	2,222
Payable/accrued	–	–	–	–	–	–
Accrued expenses	882	784	1,268	940	1,015	1,068
Short-term debt	60.0	0	0	0	150	0
Current portion of long-term debt	–	1,848	0	300	0	1.0
Other current liabilities	368	1,810	155	390	1,664	8,935
Total current liabilities	2,305	5,496	3,098	3,733	4,931	12,226
Long-term debt	3,134	5,323	7,800	7,774	10,632	15,611
Minority interest	184	443	446	448	617	566
Other liabilities	2,033	2,024	2,929	2,831	3,094	3,997
Total liabilities	7,656	13,286	14,273	14,786	19,274	32,400
Shareholders' equity
Preferred stock	–	–	–	–	–	–
Common stock	4.0	4.0	4.0	5.0	5.0	7.0
Additional paid-in capital	38,718	47,922	48,059	48,420	49,574	50,039
Retained earnings (accumulated deficit)	−24,278	−23,076	−22,874	−21,065	−23,187	−11,586
Treasury stock	–	–	–	–	–	–
Other equity	−525	−1,500	−910	−791	41.0	44.0
Total equity	13,919	23,350	24,279	26,569	26,433	38,504
Total liabilities & shareholders' equity	21,575	36,636	38,552	41,355	45,707	70,904

Cash flow statement in millions of USD, fiscal years

Cash flow statement, DuPont de Nemours, Inc., fiscal years, most recent first
	2025	2024	2023	2022	2021	2020
Operating activities
Net income	−738	738	462	5,917	6,515	−2,923
Depreciation, depletion & amortization	647	635	580	1,180	1,458	3,094
Deferred taxes	13.0	−92.0	−308	−214	−323	−692
Non-cash items	1,926	507	1,391	−4,928	−4,931	3,448
Changes in working capital	−436	59.0	−207	−1,367	−438	1,168
Cash from operations	1,412	1,847	1,918	588	2,281	4,095
Investing activities
Capital expenditures	−333	−285	−302	−743	−891	−1,194
Other investing cash flows	−354	−564	441	9,666	−1,510	992
Cash from investing	−687	−849	139	8,923	−2,401	−202
Financing activities
Financing cash flow items	3,271	−75.0	−65.0	−78.0	−249	−120
Cash dividends paid	−597	−635	−651	−652	−630	−882
Issuance (retirement) of debt, net	–	–	–	–	–	–
Other financing cash flows	−4,542	−1,137	−2,273	−6,937	−5,628	4,240
Cash from financing	−1,868	−1,847	−2,989	−7,667	−6,507	3,238
Foreign exchange effects	11.0	−62.0	−36.0	−148	−72.0	67.0
Net change in cash	−1,132	−911	−968	1,696	−6,699	7,198
Free cash flow	1,079	1,562	1,616	−155	1,390	2,901

Disclaimer

The financial data presented in this report is delayed and obtained from sources QDD Research believes to be reliable, including stock exchanges, SEDAR, and EDGAR. However, no representation or warranty is made as to the accuracy, completeness, or timeliness of the information. QDD Research accepts no liability for any errors, omissions, or financial losses arising from the use of this data.

This report is generated using a fully systematic and quantitative approach. All factor scores and the overall quant rating (ranging from D to A+) are derived from algorithmic models and are based solely on objective financial metrics. These scores are intended for informational purposes only and should not be interpreted as investment advice or a recommendation to buy, sell, or hold any securities.

QDD Research is not a registered investment advisor or broker-dealer and does not provide personalized financial advice. The content is not tailored to the specific investment goals, financial situation, or risk profile of any individual investor. We strongly encourage readers to consult with a licensed broker or investment advisor before making any investment decisions based on the information contained in this report.

Live quote provided by TradingView. Report data updated Nov 1, 2026 after market close.